Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
AIM similar filings
- 20 Feb 24 Entry into a Material Definitive Agreement
- 9 Feb 24 AIM ImmunoTech Reports Positive Topline Results from Phase 2 Study Evaluating Ampligen® for the Treatment of Post-COVID Conditions
- 25 Jan 24 Regulation FD Disclosure
- 10 Jan 24 Submission of Matters to a Vote of Security Holders
- 10 Jan 24 AIM ImmunoTech Announces Open Enrollment for Phase 1b/2 Study Evaluating
- 15 Nov 23 Regulation FD Disclosure
Filing view
External links
Exhibit 99.1